期刊文献+

1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌抑制卵巢癌细胞SKOV3侵润转移的研究 被引量:2

THE INHIBITIVE EFFECTS OF 1,8-DIHYDROXY-3-ACETYL-6-METHYL-9,10 ANTHRACENONE ON INVASIVE AND METASTASIS OF OVARIAN CARCINOMA SKOV3 CELLS
暂未订购
导出
摘要 目的:研究化合物1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌抑制卵巢癌细胞SKOV3侵润转移作用。方法:利用细胞划痕实验、MTT法、明胶酶谱实验等方法,研究1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌对SKOV3细胞侵润、黏附和迁移能力的影响。结果:1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌具有抑制SKOV3细胞运动迁移能力和抑制SKOV3细胞的黏附能力;无细胞毒作用浓度的1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌处理SKOV3细胞后,基质金属蛋白酶MMP-2、MMP-9的活性均有一定程度的降低。结论:1,8-二羟基-3-乙酰基-6-甲基-9,10蒽醌具有抑制SKOV3细胞侵润、黏附和迁移能力。 Objective: To observe the inhibitive effects of 1,8-dihydroxy-3-acetyl-6-methyl-9, 10 anthracenone on invasive and metastasis of ovarian carcinnoma cells SKOV3. Methods: Gelatin zymography, scratch movement assay in vitro and MTT assay were employed to study the mechanisms of the effects of 1,8-dihydroxy-3-acetyl-6-methyl-9,10 anthracenone. Results: The migration movement ability, adhesion ability and MMP-2, MMP-9 levels in SKOV3 were all inhibited by the nontoxic concentration of l, 8-dihydroxy-3-acetyl-6-methyl-9,10 anthracenone. Conclusion: Compared with carboplatin, 1,8-dihydroxy-3- acetyl-6- methyl-9,10 anthracenone shows stronger inhibitive effects on invasive and metastasis activity of SKOV3 cells.
出处 《广西医科大学学报》 CAS 2012年第4期496-498,共3页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.81060270 No.81060218)
关键词 1 8-二羟基-3-乙酰基-6-甲基-9 10蒽醌 卵巢癌细胞 侵润转移 1,8-dihydroxy-3-acetyl-6-methyl-9,10 anthracenone ovarian carcinoma invasive and metastasis
  • 相关文献

参考文献7

二级参考文献56

共引文献45

同被引文献32

  • 1阮和云,黎丹戎,李力,冠潇,张玮.卵巢上皮性癌淋巴道定向高转移细胞系的建立及其生物学特性的鉴定[J].中华妇产科杂志,2007,42(7):482-486. 被引量:10
  • 2Zhang I-I, Zhu W, Su X, et al.Triptolide inhibits proliferation and in- vasion of malignant glioma cells[J~.J Neurooncol,2012,109( 1 ) : 53-62.
  • 3Castillo-Lluva S,Tan CT,Daugaard M,et al.The tumour suppressor HACE1 controls cell migration by regulating Racl degradation[J]. Oncogene,2013,32(13) : 1735-1742.
  • 4Han P,Luan Y,Liu Y,et al.Small interfering RNA targeting Racl sensitizes colon cancer to dihydroartemisinin-induced cell cycle ar- rest and inhibited cell migration by suppressing NFKB activity[J]. Mol Cell Biochem,2013,379(1-2) : 171-180.
  • 5Hirsch DS,Shen Y, Wu WJ.Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is cor- related with inactivation of Cdc42 [ J ].Cancer Res, 2006,66 ( 7 ) : 3523- 3530.
  • 6Ma J,Xue Y,Liu W,et al.Role of activated rael/edc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast caner[J]. PLoS One,2013,8(6) :e66275.
  • 7Sinha S,Yang W.Cellular signaling for activation of Rho GTPase Cdc42[J ].Cell Signal, 2008,20( 11 ) : 1927-1934.
  • 8Kaibuchi K, Kuroda S, Amano M.Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells [J]. Annu Rev Biochem, 1999,68( 1 ) :459-486.
  • 9Rohatgi R,Ho HY,Kirschner MW.Mechanism of N-WASP activa- tion by CDC42 and phosphatidylinositol 4,5-bisphosphate [J].J Cell Biol,2000,150(6) : 1299-1310.
  • 10Itoh RE,Kurokawa K, Ohba Y,et al.Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells[J].Mol Cell Biol, 2002,22 ( 18 ) : 6582-6591.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部